These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3111199)

  • 1. [Prevention of experimental diabetic corneal endotheliopathy with aldose reductase inhibitor].
    Akagi Y; Takahashi Y; Tanabe T; Ikebe H; Majima K; Miyatani H; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):187-93. PubMed ID: 3111199
    [No Abstract]   [Full Text] [Related]  

  • 2. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H; Yaginuma T; Mizuno A
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):194-201. PubMed ID: 3133929
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of experimental diabetic corneal endotheliopathy with a new aldose reductase inhibitor].
    Terubayashi H; Akagi Y; Takahashi Y; Ikebe H; Miyamoto Y; Ibaraki N; Yokoi N; Tutumi M; Itoi M
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):151-5. PubMed ID: 3133928
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
    [No Abstract]   [Full Text] [Related]  

  • 5. [The intraocular penetration of aldose reductase inhibitor in rat eyes].
    Kojima M; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1988 Jan; 92(1):57-62. PubMed ID: 3133930
    [No Abstract]   [Full Text] [Related]  

  • 6. [A study of the limitations of ARI treatment of streptozotocin-induced diabetic cataracts].
    Kojima M; Sasaki K
    Nippon Ganka Gakkai Zasshi; 1986 Dec; 90(12):1669-73. PubMed ID: 2950739
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of aldose reductase inhibitor on experimental diabetic cataract monitored by laser Raman spectroscopy.
    Mizuno A; Nozawa H; Yaginuma T; Matsuzaki H; Ozaki Y; Iriyama K
    Exp Eye Res; 1987 Jul; 45(1):185-6. PubMed ID: 3115805
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
    Funada M; Okamoto I; Fujinaga Y; Yamana T
    Nippon Ganka Gakkai Zasshi; 1985 Oct; 89(10):1111-9. PubMed ID: 3938182
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H; Nozawa Y; Hayano S
    Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of aldose reductase in diabetic corneal epitheliopathy. Second report: The corneal epithelium of galactosemic rats].
    Takahashi Y; Akagi Y; Akimune M; Tamura K; Itoi M
    Nippon Ganka Gakkai Zasshi; 1986 Feb; 90(2):336-40. PubMed ID: 3085442
    [No Abstract]   [Full Text] [Related]  

  • 11. Aldose reductase inhibition, glomerular metabolism, and diabetic nephropathy.
    Cohen M
    Diabet Med; 1985 May; 2(3):203-6. PubMed ID: 3032499
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetic changes in pupillary reaction and iridal pathology. No. 1. The role of aldose reductase to the delayed pupillary reaction in galactose-fed rats].
    Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
    Nippon Ganka Gakkai Zasshi; 1988 Mar; 92(3):484-8. PubMed ID: 3137794
    [No Abstract]   [Full Text] [Related]  

  • 13. Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myo-inositol supplementation and aldose reductase inhibition.
    Goldfarb S; Simmons DA; Kern EF
    Trans Assoc Am Physicians; 1986; 99():67-72. PubMed ID: 3111062
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E
    Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetic changes in pupillary reactions and iris histology. No. 3. The role of aldose reductase inhibitor to iridal vessel hyperpermeability of galactose-fed rats].
    Kador PF; Kinoshita JH; Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
    Nippon Ganka Gakkai Zasshi; 1988 Oct; 92(10):1577-81. PubMed ID: 3145680
    [No Abstract]   [Full Text] [Related]  

  • 16. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
    Datiles M; Fukui H; Kuwabara T; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil.
    Datiles MB; Fukui H
    Curr Eye Res; 1989 Mar; 8(3):233-7. PubMed ID: 2523284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats.
    Suárez G; Rajaram R; Bhuyan KC; Oronsky AL; Goidl JA
    J Clin Invest; 1988 Aug; 82(2):624-7. PubMed ID: 3136193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
    Christensen JE; Larsen AB; Gregersen G
    Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975
    [No Abstract]   [Full Text] [Related]  

  • 20. Diminished proteinuria in diabetes mellitus by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E; Edelist T; Varagiannis E
    Pharmacology; 1986; 32(1):52-60. PubMed ID: 3080763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.